Skip to content

Evidence

Equitable impact of an AI-driven breast cancer screening workflow in real-world US-wide deployment

Nature Health
Louis et al. Nov 2025

 

Artificial intelligence shows promising results for improving early breast cancer detection and overall screening outcomes. Here the AI-Supported Safeguard Review Evaluation (ASSURE) study evaluates an AI workflow on digital breast tomosynthesis exams from women across four states to optimize early cancer detection. Implementation of the AI workflow improved screening effectiveness with equitable benefits.

Diagnostic Utility of Artificial Intelligence–assisted Transperineal Biopsy Planning in Prostate Cancer Suspected Men: A Prospective Cohort Study

European Urology Focus

Karsten et al. September 2024

 

Accurate magnetic resonance imaging (MRI) reporting is essential for transperineal prostate biopsy (TPB) planning. Although approved computer-aided diagnosis (CAD) tools may assist urologists in this task, evidence of improved clinically significant prostate cancer (csPCa) detection is lacking.

Early experiences of integrating an artificial intelligence-based diagnostic decision support system into radiology settings: a qualitative study

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, ocad191,
Nuša Farič, PhD, Sue Hinder, PhD, Robin Williams, PhD, Rishi Ramaesh, MD, Miguel O Bernabeu, PhD, Edwin van Beek, PhD, Kathrin Cresswell, PhD

Artificial Intelligence for Neuroimaging and Musculoskeletal Radiology: Overview of Current Commercial Algorithms

SEMINARS IN ROENTGENOLOGY, 2023
Elisa R. Berson, Mariam S. Aboian, Ajay Malhotra, Seyedmehdi Payabvash

Combining semi‑quantitative rating and automated brain volumetry in MRI evaluation of patients with probable behavioural variant of frontotemporal dementia: an added value for clinical practise?

DIAGNOSTIC NEURORADIOLOGY, 2023
Sonia Francesca Calloni, Paolo Quintiliano Vezzulli, Antonella Castellano, Riccardo Leone, Silvia Basaia, Almar von Loon, Edoardo Gioele Spinelli, Giuseppe Magnani, Francesca Caso, Federica Agosta, Massimo Filippi & Andrea Falini
Disclaimers: DeepHealth Prostate is manufactured as Quantib Prostate by Quantib BV for DeepHealth Inc., DeepHealth Lung is manufactured as Veye Lung Nodules by Aidence BV for DeepHealth Inc., DeepHeath Lung Tracker is manufactured as Veye Clinic by Aidence BV for DeepHealth Inc. and DeepHealth Brain is manufactured as Quantib ND by Quantib BV for DeepHealth Inc. Not all products and functionalities are commercially available in all countries. For clearance and commercial availability in your geography of functionalities listed and compatibility with other systems, please contact us